Aclaris Therapeutics, Inc. (ACRS)
USD 3.08
(-5.52%)
USD 3.08
(-5.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 31.24 Million | 29.75 Million | 6.76 Million | 6.48 Million | 4.22 Million | 10.09 Million |
| Cost of Revenue | 18.08 Million | 11.96 Million | 4.71 Million | 5.13 Million | 4.05 Million | 6.85 Million |
| Gross Profit | 13.16 Million | 17.79 Million | 2.04 Million | 1.34 Million | 172 Thousand | 3.24 Million |
| Operating Expenses | 110.52 Million | 102.94 Million | 67.43 Million | 52.26 Million | 92.72 Million | 138.65 Million |
| Selling, General and Administrative Expenses | 31.09 Million | 25.13 Million | 23.61 Million | 20.53 Million | 27.82 Million | 75.64 Million |
| Research and Development Expenses | 98.38 Million | 77.81 Million | 43.81 Million | 31.73 Million | 64.89 Million | 63 Million |
| Other Expenses | - | 2.94 Million | -1.14 Million | -424 Thousand | -2.48 Million | 2.67 Million |
| Cost and Expenses | 128.6 Million | 114.9 Million | 72.14 Million | 57.39 Million | 96.78 Million | 145.5 Million |
| Operating Income | -97.35 Million | -85.15 Million | -65.38 Million | -50.91 Million | -111.05 Million | -135.41 Million |
| Interest Expense | - | 4.7 Million | - | - | - | - |
| Income Tax Expense | -367 Thousand | 1.75 Million | 23.41 Million | -182 Thousand | 29.3 Million | 2.67 Million |
| Earnings before Tax | -88.84 Million | -86.9 Million | -90.86 Million | -51.33 Million | -113.54 Million | -132.73 Million |
| Net Income | -88.48 Million | -88.66 Million | -114.28 Million | -51.15 Million | -142.85 Million | -132.73 Million |
| Earnings Per Share Basic | -1.27 | -1.36 | -2.01 | -1.20 | -3.46 | -4.03 |
| Earnings Per Share Diluted | -1.27 | -1.36 | -2.01 | -1.20 | -3.46 | -4.03 |
| Weighted Average Shares Outstanding | 69.8 Million | 65.21 Million | 56.73 Million | 42.53 Million | 41.32 Million | 32.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.8 Million | 65.21 Million | 56.73 Million | 42.53 Million | 41.32 Million | 32.9 Million |
| Gross Margin | 0.42 | 0.60 | 0.30 | 0.21 | 0.04 | 0.32 |
| EBIT Margin | -3.76 | -2.68 | -6.07 | -7.85 | -17.52 | -13.42 |
| Profit Margin | -2.83 | -2.98 | -16.90 | -7.89 | -33.79 | -13.15 |
| EBITDA | -117.56 Million | -84.35 Million | -65.06 Million | -48.19 Million | -90.83 Million | -80.78 Million |
| Earnings Before Tax Margin | -3.12 | -2.86 | -9.67 | -7.85 | -26.27 | -13.42 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.76 Million | 2.39 Million | 31.24 Million | 17.57 Million | 9.28 Million | 1.86 Million |
| Cost of Revenue | 1.9 Million | 1.84 Million | 18.08 Million | 6.42 Million | 848 Thousand | 1.59 Million |
| Gross Profit | 857 Thousand | 558 Thousand | 13.16 Million | 11.14 Million | 8.43 Million | 277 Thousand |
| Operating Expenses | 13.41 Million | 14.18 Million | 129.48 Million | 34.86 Million | 40.01 Million | 33.59 Million |
| Selling, General and Administrative Expenses | 4.65 Million | 4.34 Million | - | 8.21 Million | 7.09 Million | 8.31 Million |
| Research and Development Expenses | 8.75 Million | 9.84 Million | - | 26.64 Million | 23.87 Million | 25.27 Million |
| Other Expenses | 1.86 Million | 1.99 Million | 8.5 Million | 2.18 Million | 9.04 Million | 2.24 Million |
| Cost and Expenses | 15.32 Million | 16.02 Million | 147.56 Million | 41.28 Million | 40.85 Million | 35.18 Million |
| Operating Income | -12.55 Million | -13.63 Million | -97.35 Million | -4.04 Million | -31.57 Million | -31.81 Million |
| Interest Expense | - | - | - | 1.6 Million | - | - |
| Income Tax Expense | - | 199.72 Thousand | -367 Thousand | -367 Thousand | -219 Thousand | -1.5 Million |
| Earnings before Tax | -10.98 Million | -16.94 Million | -88.84 Million | -1.85 Million | -29.26 Million | -29.56 Million |
| Net Income | -10.98 Million | -16.94 Million | -88.48 Million | -1.49 Million | -29.26 Million | -29.56 Million |
| Earnings Per Share Basic | -0.15 | -0.24 | - | -0.02 | -0.41 | -0.42 |
| Earnings Per Share Diluted | -0.15 | -0.24 | - | -0.02 | -0.41 | -0.42 |
| Weighted Average Shares Outstanding | 71.29 Million | 71.07 Million | 69.8 Million | 70.86 Million | 70.8 Million | 70.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 71.29 Million | 71.07 Million | 69.8 Million | 70.86 Million | 70.8 Million | 70.63 Million |
| Gross Margin | 0.31 | 0.23 | 0.42 | 0.63 | 0.91 | 0.15 |
| EBIT Margin | -4.47 | -5.58 | - | -2.46 | -3.40 | -18.51 |
| Profit Margin | -3.97 | -7.06 | -2.83 | -0.08 | -3.15 | -15.82 |
| EBITDA | -12.35 Million | -13.38 Million | - | -43.16 Million | -31.57 Million | -34.59 Million |
| Earnings Before Tax Margin | -4.54 | -5.68 | -3.12 | -0.23 | -3.40 | -17.02 |
MGTX
TSG
WFX
SYTAW
0QAV
AVA